Expressing the sense of the Congress that the National Institutes of Health should encourage a global pediatric clinical trial network, and for other purposes.

Bill: 114-hconres-46
Sponsor: full_name: Rep. Pitts, Joseph R. [R-PA-16]
Introduced: 2015-05-14
Policy area: Health
Subjects: Child health

Department of Health and Human Services

Drug safety, medical device, and laboratory regulation

Europe

International organizations and cooperation

Medical research

National Institutes of Health (NIH)

Research administration and funding
Latest action: action_date: 2015-05-15
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2015-05-14
action_desc: Introduced in House
text: <p>Expresses the sense of Congress that:</p> <ul> <li> the National Institutes of Health (NIH) should encourage a global pediatric clinical trial network through the allocation of grants, contracts, or cooperative agreements to supplement the salaries of new and early investigators who participate in it;</li> <li>NIH grants, contracts, or cooperative agreements should be awarded to participating entities, solely for the purpose of supplementing the salaries of such investigators; and</li> <li> the Food and Drug Administration (FDA) should engage the European Medicines Agency and other foreign regulatory entities during the formation of such network to encourage their participation and should continue to engage such entities, once such network becomes operational, to encourage and facilitate their participation with the goal of enhancing the network's global reach.</li> </ul> <ul> </ul>

tv_txt: IV 114th CONGRESS 1st Session H. CON. RES. 46 IN THE HOUSE OF REPRESENTATIVES May 14, 2015 Mr. Pitts submitted the following concurrent resolution; which was referred to the Committee on Energy and Commerce CONCURRENT RESOLUTION Expressing the sense of the Congress that the National Institutes of Health should encourage a global pediatric clinical trial network, and for other purposes.

That it is the sense of the Congress that— (1) the National Institutes of Health should encourage a global pediatric clinical trial network through the allocation of grants, contracts, or cooperative agreements to supplement the salaries of new and early investigators who participate in the global pediatric clinical trial network; (2) National Institutes of Health grants, contracts, or cooperative agreements should be awarded, solely for the purpose of supplementing the salaries of new and early investigators, to entities that participate in the global pediatric clinical trial network; (3) the Food and Drug Administration should engage the European Medicines Agency and other foreign regulatory entities during the formation of the global pediatric clinical trials network to encourage their participation; and (4) once a global pediatric clinical trial network is established and becomes operational, the Food and Drug Administration should continue to engage the European Medicines Agency and other foreign regulatory entities to encourage and facilitate their participation in the network with the goal of enhancing the global reach of the network.